Clinical Trials in Salt Lake City

Showing 3901-3920 of 16,694 trials

A Study of Abemaciclib in Recurrent Glioblastoma

NCT02981940

This research study is studying a targeted therapy as a possible treatment for recurrent glioblastoma (GBM). The following intervention will be used in this study: -Abemaciclib

Glioblastoma

Dana-Farber Cancer Institute45 participantsStarted Feb 2017

Los Angeles, California, United States • San Francisco, California, United States • Boston, Massachusetts, United States +4 more locations

RECRUITINGPhase 3< 1 mile

A Study of EPX-100 (Clemizole Hydrochloride) in Participants With Dravet Syndrome

NCT04462770

This is a multicenter, Phase 3, randomized, double-blind, placebo-controlled study designed to evaluate the efficacy and safety of clemizole hydrochloride (EPX-100) as adjunctive therapy in children and adult participants with Dravet syndrome (DS).

Dravet Syndrome

Epygenix150 participantsStarted Sep 2020

Los Angeles, California, United States • Orange, California, United States • San Francisco, California, United States +43 more locations

A Study of Abemaciclib in Recurrent Glioblastoma

A Study of EPX-100 (Clemizole Hydrochloride) in Participants With Dravet Syndrome

Find Trials by Condition in Salt Lake City

Clinical Trial of Brentuximab Vedotin in Classical Hodgkin Lymphoma

A Study of LY3549492 in Adults With Obesity or Overweight With Type 2 Diabetes

A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2)

A Study Investigating DNA-damage Response Agents in Molecularly Altered Advanced Cancer

A Study to Evaluate the Safety and Efficacy of NG101 in Adult Participants With Symptomatic Diabetic or Idiopathic Gastroparesis

A Study of the Safety, Tolerability, and Pharmacokinetics of Dolutegravir in Neonates Exposed to HIV-1

Ferric Citrate for the Prevention of Renal Failure in Adults With Advanced Chronic Kidney Disease

Genetic Testing in Screening Patients With Metastatic or Unresectable Colon or Rectal Cancer for a COLOMATE Trial

A Study of LY3549492 in Healthy Weight Adult Participants

Mitral Valve Screening Survey

Long-Term Evaluation of BIIB067 (Tofersen)

A Study of Adjuvant Intismeran Autogene (V940) and Pembrolizumab in Renal Cell Carcinoma (V940-004).

Post-approval Study of New Enrolment Patients Undergoing Bilateral Treatment With the VisuMax SMILE Procedure

Multimodal Intervention for Cachexia in Advanced Cancer Patients Undergoing Chemotherapy

Telehealth 2.0: Evaluating Effectiveness and Engagement Strategies for CPT-Text for PTSD

Treatment of GVHD in Hematopoietic Stem Cell Transplant (HSCT) Recipients Using AAT Plus Corticosteroids (CS) Compared With Corticosteroids Alone

Effect of Evolocumab on Saphenous Vein Graft Patency Following Coronary Artery Bypass Surgery

Tucatinib, Trastuzumab, and Capecitabine for the Treatment of HER2+ LMD